Purpose: Patient-specific quality assurance (QA) measurement is conducted to confirm the accuracy of dose delivery. However, measurement is time-consuming and places a heavy workload on the medical physicists and radiological technologists. In this study, we proposed a prediction model for gamma evaluation, based on deep learning. We applied the model to a QA measurement dataset of prostate cancer cases to evaluate its practicality. Methods: Sixty pretreatment verification plans from prostate cancer patients treated using intensity modulated radiation therapy were collected. Fifteen-layer convolutional neural networks (CNN) were developed to learn the sagittal planar dose distributions from a RT-3000 QA phantom (R-TECH.-INC., Tokyo, Japan). The percentage gamma passing rate (GPR) was measured using GAFCHRO-MIC EBT3 film (Ashland Specialty Ingredients, Covington, USA). The input training data also included the volume of the PTV (planning target volume), rectum, and overlapping region, measured in cm 3 , and the monitor unit values for each field. The network produced predicted GPR values at four criteria: 2%(global)/2 mm, 3%(global)/2 mm, 2%(global)/3 mm, and 3%(global)/3 mm. Adam, an algorithm for first-order gradient-based optimization of stochastic objective functions, was used for learning and for optimizing the CNN-based model. Fivefold cross-validation was applied to validate the performance of the proposed method. Forty cases were used for training and validation set in fivefold cross-validation, and the remaining 20 cases were used for the test set. The predicted and measured GPR values were compared. Results: A linear relationship was found between the measured and predicted values, for each of the four criteria. Spearman rank correlation coefficients in validation set between measured and predicted GPR values at four criteria were 0.73 at 2%/2 mm, 0.72 at 3%/2 mm, 0.74 at 2%/3 mm, and 0.65 at 3%/3 mm, respectively (P < 0.01). The Spearman rank correlation coefficients in the test set were 0.62 (P < 0.01) at 2%/2 mm, 0.56 (P < 0.01) at 3%/2 mm, 0.51 (P = 0.02) at 2%/3 mm, and 0.32 (P = 0.16) at 3%/3 mm. These results demonstrated a strong or moderate correlation between the predicted and measured values. Conclusions: We developed a CNN-based prediction model for patient-specific QA of dose distribution in prostate treatment. Our results suggest that deep learning may provide a useful prediction model for gamma evaluation of patient-specific QA in prostate treatment planning.
INTRODUCTION
Modern radiotherapy techniques, including intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT), allow a complex dose distribution to be applied, minimizing the damage done to healthy tissues. 1 However, these techniques are highly complex in both planning and delivery, and must be thoroughly safety tested prior to implementation. 2 Patient-specific pretreatment quality assurance (QA) is an important step in the treatment process, and it has been widely rated as essential. 3 The process typically involves comparing the calculated dose distribution with the measured dose distribution, using a gamma evaluation. 4 This form of evaluation has become the mainstay of patientspecific QA, when applied to IMRT and VMAT. It is recommended in a number of institutional guidelines and is a readily available, efficient tool for assessing the accuracy of patient-specific treatment delivery. 3, 5, 6 Gamma evaluation allows the agreement between two dose distributions to be evaluated in a combined dose-spatial domain. 4 The agreement in percentage of the dose points is referred to as the gamma passing rate (GPR). In most cases, the full distribution of c values is not considered when calculating the GPR. Instead, only values in the region of interest or values corresponding to a dose that exceeds a user-defined lower threshold are typically considered. The result is therefore influenced by user-defined criteria: the dose difference, DD (% global or local), and distance-to-agreement, Dd (mm).
However, the implementation of patient-specific QA using gamma evaluation and point dose measurement is timeconsuming. 7 Currently, the patient-specific QA requires a measurement using phantom or device in every treatment plan before it begins. Given the necessity of confirming an IMRT plan for each patient, currently available patient-specific IMRT QA techniques impose a heavy clinical workload burden.
A UK survey of patient-specific QA practice noted that recent approaches have reduced the role of measurement and it reported a move away from individual patient measurement, especially in prostate treatment. 8 To solve the problems related to the workload, a practical and precise predictive method has been reported. The prediction models reported in previous studies have used the 3D predicted dose, with the gamma evaluation of the planar dose distribution conducted using criteria greater than 3%(global)/3 mm. 9 , 10 Valdes et al. discussed machine learning-based prediction models, in which gamma evaluation was performed using criteria of 3% (local)/3 mm. 11, 12 However, recent publications have suggested that criteria stricter than 3%(global)/3 mm be applied for IMRT plan gamma evaluation for error detection. 13, 14 Nelms et.al. reported that 2%(local)/2 mm was the most sensitive criterion to detect clinically relevant errors.
14 On the other hand, TG 218 recommended that the global normalization method and true composite delivery method, in which all beams were delivered in the actual treatment setting, should be used for IMRT QA measurement. 15 The criteria should be selected based on the measurement device and situation. A new gamma prediction model is needed to reflect the recent reassessment of the recommended IMRT QA measurement in the true composite delivery and global normalization methods.
Interian et al. investigated the feasibility of using transfer learning with VGG-16 ImageNet model and predicted the GPR value in 3%(local)/3 mm. 16 The use of deep learning for predicting QA results has been recently developed, and it has the potential to accurately predict GPR values. In pursuit of the goal, in this study, we developed a novel prediction model based on a deep learning convolutional neural network (CNN). A model proposed in this study is able to predict GPR values based on multiple criteria along with global normalization and to experimentally test the feasibility of a model using a dataset of patient-specific QA results. Figure 1 shows a schematic diagram of the concept. The study focused on prostate cancer treatment, with the goal of predicting the GPR value on a planar dose distribution in a verification measurement.
MATERIALS AND METHODS

2.A. Overview of dose distribution verification
Sixty prostate cancer treatment plans, which were continuously treated from May 2015 to June 2017, were selected from the iPlan Dose ver. 4.1.2 (BrainLAB, Munich, Germany) treatment planning system (TPS) used by our hospital. All cases underwent prostate and partial seminal irradiation. Some irregular treatment cases, including pelvic nodes or other sites, were excluded. The cases were planned using seven-field IMRT, and almost the same gantry angle was used in all cases. The dose calculation algorithm was implemented using a Monte Carlo approach. All plans were verified using an RT-3000 QA phantom (R-TECH.INC, Tokyo, Japan) and GAFCHROMIC EBT3 film (Ashland Specialty Ingredients, Covington, USA). The patient treatment plans were applied to the QA phantom, which was exposed to the planned fluence. The film was inserted at the center of the phantom, in the sagittal plane. After exposure, the sagittal planar dose distribution on the film was scanned and 2D gamma analysis was performed to compare the calculated and measured dose distributions. The gamma agreement index and percentage GPR were then calculated. The gamma agreement index values were calculated using four gamma criteria pairings: 2%(-global)/2 mm, 2%(global)/3 mm, 3%(global)/2 mm, and 3% (global)/3 mm. The GPR was defined as the percentage of points for which the gamma index was less than one, and the dose evaluation region as that in which the dose exceeded more than 30% of maximum dose. This relatively high threshold value was chosen to minimize the effect of noise arising from the use of EBT3 film. 17 The measured GPR results of four criteria were used for the supervised learning.
2.B. Datasets for CNN
The dose distribution was calculated from the TPS and extracted in comma-separated value format, with a height of 138 mm, width of 151 mm, and pixels of 1 mm in height and width. The data were held in a 138 9 151 matrix containing dose distribution information in gray (Gy) units. Sixty sagittal planar dose distributions in the QA phantom were collected in the same format. Three types of information were used as input data for deep learning. The first set comprised the sagittal planar dose distributions on the isocenter, the second set comprised the volumes of the PTV and rectum, and of the overlapping regions between the structures, measured in cm 3 , and the third set comprised the monitor unit (MU) values for each field. The three volumes were structured by the same physician. Prostate and base of seminal vesicle were defined as CTV, and PTV was defined as the enlarged structure of CTV to entire perimeter with 7mm, except for posterior with 5mm. Previous studies reported that the GPR was affected by the complexity of the plan. The number of MU was a factor for assessing beam and overall plan complexity and deliverability. 11, [18] [19] [20] [21] In terms of volume, several studies have reported that patient geometric features were correlated with plan complexity and quality, especially PTV, OAR (rectum), and the overlapping region. 22, 23 We therefore used the MU and volume as additional input information. For supervised learning, the measured GPR values of four criteria were used as the training data output values. The 40 cases were used for training and validation set in fivefold cross-validation, and the remaining 20 cases were used for the test set. Figure 2 shows a schematic diagram of the CNN architecture used in this study. This comprised 15 layers at the longest stream, and contained three convolutional layers, three activation layers (one ELU layer and two ReLU layers), and three Max pooling layers. 24, 25 A random dropout layer was employed to mitigate overfitting, 26 and an affine layer with 20 neurons was placed after this. The dose distribution data were analyzed through these layers. The volume values and the MU values were analyzed through relatively simple layers comprising two affine layers with 20 neurons and a random dropout layer. The drop rates of the three drop layers in this CNN were set to 0.25. The three input streams were connected to the residual layer to integrate the information. The output from this residual layer was the sum of the three scalar values from the three upstream affine layers in each neuron. Finally, the residual layer was connected to four final affine single-neuron layers to predict the GPR values for the four gamma criteria. The Huber loss function was applied in the output layer to ensure stable learning, 27 and multi-target regression was used to predict all four results at once. The specifications of the layers are summarized in Table I . The hyper-parameters were determined by a random search method with a training set of 40 cases.
2.C. Architecture of the CNN
2.D. Setting and environment
The network was optimized using an algorithm called Adam, derived from adaptive moment estimation. This was selected for its robustness. It is applied to a wide range of optimization problems in machine learning, as it requires little memory and is computationally efficient when used for gradient-based optimization. 28 During a training process, the parameters, weights, and biases of the CNN were changed many times through the learning iteration called an epoch. In this study, the weight and bias values were set at the best epoch in which the validation error was a minimum value. If the learning iteration was done with one case, the best epoch depended on a randomly selected single case, and it could result in unstable learning and a lack of generality. To perform a stable training, we used the mini-batch method in which a learning iteration is implemented with several randomly selected data. The mini-batch was set to eight and the number of epochs to 3000. Training was conducted on a PC with an Intel(R) Core(TM) i7-6700K 4.0 GHz CPU and 4 GB of RAM. No GPU was used. Full training of the CNN with fivefold cross-validation described below took approximately 2 h in this environment.
2.E. Model training and evaluation
We used 40 cases for training and validation sets and used the remaining 20 cases for the test set to evaluate the trained models. Figure 3 shows the workflow of the training and evaluation process. In this study, we implemented a fivefold cross-validation method. In each fold, we obtained a trained model and a validation result of eight cases. By collecting each validation result from all five folds, we acquired the validation results of 40 cases. Through this fivefold cross-validation, the five trained models were produced. To reduce generalization error, we used model averaging. We applied the test set to each trained model and then averaged the test results from the five trained models to acquire the mean test result. The validation result and mean test result are summarized in the Results section.
2.F. Comparison between CNN architecture patterns and the linear regression model
As depicted in Fig. 2 , we produced a CNN model that had three input branches for accepting dose distribution, volumes, and MU. To reveal the contributions from each branch, we implemented several architecture patterns and then evaluated them. Figure 4 presents the list of architecture patterns. Pattern 1 had three branches, which is the same as Fig. 2 . Patterns 2 and 3 had two branches, both of which dealt with dose distribution. The difference between them was that another branch of pattern 2 dealt with volume and pattern 3 dealt with MU values. Pattern 4 had only one branch and dealt with dose distribution.
In addition, we implemented a machine learning model. Several prior studies have reported that machine learning models, using information from TPS, were useful for prediction of various factors. 11, 29, 30 In this study, we also implemented a machine learning-based linear regression model to predict GPR. The volume of three structures and MU values of each field were input into the linear regression model. The fivefold cross-validation method was implemented, and after acquiring the trained model, the test set was applied. The evaluation results of these CNN architecture models and the linear regression model are summarized in the Results section.
RESULTS
The GPR values predicted by the model are plotted against the measured values in Fig. 5 . If the prediction accuracy had been perfect, the points would form a diagonal line on the graph. In practice, the predicted GPR values deviated from the measured values, though linearity between the two was observed for each of the four gamma criteria. Figure 6 shows a boxplot of each group of four criteria results in validation set and test set, and Table II lists mean values, standard deviations, median values, mean absolute error (MAE), root mean squared error (RMSE), and Spearman rank correlation coefficients. In all four criteria groups, the difference of mean values and median values between predicted and measured values in both the validation and test set was less than 1%, except for 2%/2 mm in the test set (<2%). The Spearman rank correlation coefficients between measured and predicted GPR values at four criteria in the validation set were 0.73 at 2%/2 mm, 0.72 at 3%/2 mm, 0.74 at 2%/3 mm, and 0.65 at 3%/3 mm, respectively (P < 0.01). On the other hand, the Spearman rank correlation coefficients in the test set were 0.62 (P < 0.01) at 2%/2 mm, 0.56 (P < 0.01) at 3%/2 mm, 0.51 (P = 0.02) at 2%/3 mm, and 0.32 (P = 0.16) at 3%/3 mm. This confirmed a strong or moderate correlation between the measured and predicted values. Figure 7 shows the difference between measured and predicted GPR values for each case. The standard deviations in the validation set were 2.2% at 2%/2 mm, 1.5% at 3%/2 mm, 1.2% at 2%/3 mm, and 0.9% at 3%/3 mm, with maximum differences of 5.8%, 4.5%, 4.7%, and 3.0%, respectively. Test set standard deviations were 1.9% at 2%/2 mm, 1.3% at 3%/ 2 mm, 1.4% at 2%/3 mm, and 1.1% at 3%/3 mm, with Medical Physics, 45 (9), September 2018 maximum differences of À3.6%, À3.0%, À2.8%, and À2.3%, respectively. The standard deviations of the differences between validation and test results were almost the same. Figure 8 shows the relationships between the GPR values from this study at the criteria of 2%/2 mm, 3%/2 mm, 2%/ 3 mm, and 3%/3 mm. The solid and dotted lines represent linear approximations based on the least mean squares method. The linear relationships between the criteria were observed. accurate result in MAE, RMSE, and Spearman rank correlation coefficient. Comparing the results of patterns 1, 2, and 3, MAE and RMSE improved by inputting volume and MU values. The results of the linear regression model were also presented and the MAE and RMSE, in both the validation and test sets, were almost the same as those of patterns 1 and 2. However, the Spearman rank correlation coefficient decreased in the test set.
DISCUSSION
The GPR values predicted by the CNN-based model proposed in this study were strongly or moderately linearly correlated with the measured values for both the validation and test results. These results demonstrated the CNN to have successfully learned the features in the input data, producing predictions of GPR values. The CNN-based model output predicted GPR values at four criteria: 3%/3 mm, which is a widely and conventionally used criterion; 3%/2 mm, which is the criterion recommended in the TG218 report; and the other strict criteria of 2%/3 mm and 2%/2 mm. The model was demonstrated to adapt to these recent trends in gamma evaluation. The multi-institution study of gamma evaluation conducted by Scott et al. reported linear relationships between the above criteria. 31 Our own results presented in Fig. 8 , also suggested linear relationships between the criteria. Our predicted GPR values were therefore in agreement with the results from previous studies. The comparison results shown in Fig. 9 and Table III revealed that the prediction accuracy improved after adding the volume and MU branches. Although the pattern 4 model, where only the dose distribution branch was able to predict GPR values, the MAE and each criterion (pattern 1; Fig. 4 RMSE in the test set were larger than those in the other models. On the other hand, linear regression model could predict GPR values of the validation set accurately, in terms of MAE and RMSE. However, the Spearman rank correlation coefficient of the linear regression model in the test set was lowest in all other models in Fig. 9 . The Spearman rank correlation coefficient for the test result obtained using the linear regression model was 0.36, which decreased from the validation result of 0.70. As shown by the linear regression analysis plot indicated in Fig. 9 , some outlier test results were observed, implying that this linear regression model could not adapt to a specific test case and that the trained linear regression model lacked robustness to new data. Alternatively, the outliners improved in test results using CNN models. This indicated that the CNN model with dose distribution was able to acquire robustness. As a result, the Spearman rank correlation coefficient for the test result of the CNN model was improved compared with that for the test result of the linear regression model. Given these results, the CNN model with dose distribution can be useful for predicting GPR values with additional information helping to improve the prediction accuracy, and may help to acquire the robustness for analyzing new data. However, the match between measured and predicted GPR was not perfect, and large differences were observed especially in cases where the measured GPR value was low. In Fig. 7 , the maximum differences in validation set arose from a single case, which suggested either or both that the model used in the study was unable to adapt to this particular case and/or that the amount of noise present in the case produced an incorrect measured value. In all four criteria groups, The CNN-based model proposed in this study tended to overestimate the GPR in the validation set, especially in cases where the GPR value was low. On the other hand, the model tended to underestimate the GPR in the test set. These differences suggested that the model did not possess perfect generality, and produced a bias in both results. Furthermore, differences in prediction accuracy between the validation and test results were also observed. In Table II , The MAE and RMSE of the test results were larger than those of the validation results, and the Spearman rank correlation coefficients of the test results were lower than the validation results. Thus, the trained model could adopt to the test set, albeit imperfectly. These differences were assumed to be caused by specific factors that reduced the learning accuracy of the CNN. The first factor was the small volume of training data used. The accuracy with which a CNN learns is directly related to the number of training data in the input. However, the balance of the input data, that is, the balance between cases with high GPR values and cases with low GPR values, was also plays an important role in the accuracy of learning. If cases with high GPR values are over-represented in the input, the accuracy of learning and prediction will be lower. In the prostate treatment dataset used in this study, only 15 cases had GPR values lower than 85% when the 2%/2 mm criterion was applied. This limited the usefulness of the training data. To improve the prediction accuracy of the model, the number of training cases should be increased, and the balance of the data should be kept. The second factor concerned the accuracy of dose distribution measurement in the input data. Measurements were taken using EBT3 film, and errors may have been introduced by the response homogeneity of the film, the light scanning effect, the calibration of the film, and the setup of the phantom, among other things. 17 These errors would introduce noise into the input data, which in turn would render the predictions less accurate. This effect was especially pronounced in the 2%/2 mm case.
Despite these drawbacks, the CNN-based model proposed in this study successfully learned the features in the input data, and predicted GPR values with more strict criteria than 3%/3 mm. Rather, strict criteria, that is, 2%/2 mm, may be more suitable for learning than the 3%/3 mm criteria. This can be inferred from the results in Table II , in which the Spearman rank correlation coefficient of 3%/3 mm was lower than the other three criteria for both the validation and test results. It is possible that the 3%/3 mm criterion inadequately detected measurement error, resulting in a mismatch between measured and predicted GPR values. This inference is supported by previous studies that reported the insensitivity of the 3%/3 mm criterion. [13] [14] [15] Although the MAE and RMSE were minimal in the 3%/3 mm, the stricter criteria, that is, 2%/2 mm, may be more suitable for prediction from the viewpoint of detecting the plan to which we should pay attention. As training was based on the dose distribution in a QA phantom, this may have produced a more direct causal analysis. The dose distribution has spatial information and contains indirect factors that may increase the complexity of dose delivery. As shown in Fig. 9 , the CNN architecture pattern 4, which accepted only dose distribution, was also able to predict GPR via a moderate linear correlation. Data on the dose distribution can be suitable for use in predicting gamma evaluation.
The CNN-based model proposed in this study used three types of input information that can be readily collected from any TPS, and it predicted GPR values in four criteria with global normalization. Clinically, the 2%(Local)/2 mm criterion is the most sensitive to clinically relevant errors. However, selecting the local normalization will also cause the low-dose regions to have unrealistic requirements for dose accuracy. 15 We therefore constructed the novel model with the measurement data, including global normalization, to adapt to patient-specific QA. The CNN model has a relatively simple structure, which can mitigate the overfitting caused by a limited amount of training data. This simplicity can be beneficial in clinical situations because accumulating large clinical datasets can be time-consuming, making it difficult to implement a CNN model. In addition, simplicity can reduce the learning period; furthermore, the model used in this study can be run on a standard PC without GPU. The results of this study suggested that a CNN model with dose distribution was able to predict the GPR value as well as a linear regression model in terms of MAE and RMSE and could have a potential to increase the prediction accuracy considering robustness to new data. However, the CNN model is more complex than traditional machine learning, making it difficult to interpret the model. Therefore, carefully verifying a trained CNN model with test data and evaluating the prediction accuracy through various analyses are essential for clinical usage. Although the extent to which measurements can be reduced depends on the accuracy of the CNN output, the prediction model is practical and can help clinical workers reduce the measurement burden of patient-specific QA when verifying the dose distribution.
CONCLUSIONS
In this study, we developed a CNN-based prediction model for patient-specific QA of dose distribution in prostate treatment. As training data, three types of information were used: sagittal planar dose distributions from a QA phantom, the volume of the PTV and rectum and the overlapping region between them, and the MU values for each irradiation field. Strong or moderate correlations were found between the measured and predicted GPR values, and dose distribution can be a useful data for GPR prediction. Our results suggest that deep learning can be applied to the prediction of patient-specific QA dose distributions in prostate treatment.
